Hatteras Venture Partners of Durham, N.C. has closed its third fund with $60 million in capital commitments. The Durham, N.C.-based firm focuses on seed and early-stage opportunities in the pharma, medical device and medical diagnostics spaces. In related news, Hatteras has added two general partners: Robert Ingram, former CEO of GlaxoWellcome, and Douglas Reed, a […]
Picsel Group Ltd., a UK-based provider of a mobile content platform, has raised $46.5 million in third-round funding. Capital International led the deal, and was joined by Doll Capital, NIF, SMBC Ventures Co., SBI Investment Co. and DoCoMo.com. www.picsel.com www.capgroup.com
Pontis Ltd., an Israel-based provider of software marketing systems for communications services providers, has raised $15 million in second-round funding. Sequoia Capital led the deal, and was joined by return backers Evergreen Ventures and Accel Partners. www.pontis.com
Cambridge Information Group has acquired ProQuest Information and Learning from ProQuest Co. (NYSE: PQE) for $222 million. ABRY Partners provided equity financing, while leverage was arranged by Morgan Stanley Senior Funding and Goldman Sachs Credit Partners. CIG will merge ProQuest I&L with existing subsidiary CSA.
TomoTherapy Inc., a Madison, Wis.-based developer of cancer treatment systems that use on-board CT imaging and conformal radiation therapy, has filed for a $201.25 million IPO. It plans to trade on the Nasdaq under ticker symbol TTPY, with Merrill Lynch serving as lead underwriter. The company has raised around $79 million in VC funding since […]
Alliance Semiconductor Corp. has agreed to sell its 79.31% stake in Solar Venture Partners for $5 million in cash to Willowridge and Thomas Weisel Partners. SVP portfolio companies include Crosslayer Networks, Epiance and Ontologent.
Peter Bitter has joined Home Depot as a director in the company's strategic business development group. He previously was an I-banker with P&M Corporate Finance, which was focused on middle-market companies. www.homedepot.com
Optimer Pharmaceuticals Inc., a San Diego-based developer of anti-infective products, priced seven million common shares at $7 per share, for an IPO take of approximately $49 million. It originally planned to sell 5.25 million shares at between $12-$14 per share, and later lowered the range for $8-$9 per share. It will trade on the Nasdaq […]
SigmaBleyzer has closed its fourth private equity fund focused on Southeastern Europe with Euro 250 million in capital commitments. www.sigmableyzer.com
Fortress Investment Group, a New York-based alternative asset manager, priced 34.2 million shares at $18.50 per share ($16.50-$18.50 range), for an IPO take of approximately $632.7 million. The IPO gives Fortress a market cap of approximately $7.4 billion. www.fortressinv.com